Heron Neutron Medical Corp. (TPE:7799)
Taiwan · Delayed Price · Currency is TWD 357.00
-4.50 (-1.24%)
At close: Aug 6, 2026
Heron Neutron Medical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 536.34 | 2,349 | 723.97 | 233.27 | 7.87 |
Short-Term Investments | 8,880 | 7,880 | 100 | - | - |
Trading Asset Securities | - | - | - | - | 148.25 |
Cash & Short-Term Investments | 9,416 | 10,229 | 823.97 | 233.27 | 156.12 |
Cash Growth | 1521.36% | 1141.39% | 253.23% | 49.42% | - |
Accounts Receivable | - | 0.33 | - | - | - |
Other Receivables | 74.27 | 56.2 | 36.06 | 27.56 | 7.17 |
Receivables | 74.27 | 56.53 | 36.06 | 27.56 | 7.17 |
Inventory | 286.21 | 251.39 | 52.34 | 0.01 | - |
Prepaid Expenses | 14.35 | 16.17 | 3.78 | 0.68 | 14.57 |
Total Current Assets | 10,038 | 10,553 | 916.15 | 261.51 | 177.86 |
Property, Plant & Equipment | 805.03 | 575.44 | 588.05 | 261.97 | 213.16 |
Long-Term Investments | 244.03 | 415.03 | - | - | - |
Other Intangible Assets | 32.04 | 34.25 | 36.38 | 42.17 | 47.6 |
Other Long-Term Assets | 374.79 | 1.19 | 3.81 | 269.46 | 192.44 |
Total Assets | 11,494 | 11,579 | 1,544 | 835.11 | 631.06 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 29.48 | 13.26 | 0.22 | - | - |
Current Portion of Leases | 14.31 | 5.54 | 3.96 | 3.9 | 3.84 |
Other Current Liabilities | 30.16 | 45.98 | 40.11 | 15.29 | 23.33 |
Total Current Liabilities | 73.94 | 64.78 | 44.3 | 19.2 | 27.17 |
Long-Term Leases | 221.55 | 1.69 | 5.55 | 9.51 | 13.42 |
Other Long-Term Liabilities | 33.58 | 22.84 | 22.11 | - | - |
Total Liabilities | 329.07 | 89.3 | 71.96 | 28.71 | 40.59 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 1,580 | 1,575 | 1,394 | 1,140 | 800 |
Additional Paid-In Capital | 10,415 | 10,893 | 654.11 | - | - |
Retained Earnings | -165 | -481.67 | -595.99 | -335.92 | -209.53 |
Comprehensive Income & Other | -665.47 | -497.63 | 20.76 | 2.32 | - |
Shareholders' Equity | 11,165 | 11,489 | 1,472 | 806.4 | 590.48 |
Total Liabilities & Equity | 11,494 | 11,579 | 1,544 | 835.11 | 631.06 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 235.86 | 7.23 | 9.51 | 13.42 | 17.26 |
Net Cash (Debt) | 9,180 | 10,221 | 814.45 | 219.85 | 138.86 |
Net Cash Growth | 1501.54% | 1155.00% | 270.46% | 58.33% | - |
Net Cash Per Share | 59.38 | 70.17 | 6.38 | 2.05 | 1.82 |
Filing Date Shares Outstanding | 158 | 157.51 | 139.36 | 139.36 | 76.26 |
Total Common Shares Outstanding | 158 | 157.51 | 139.36 | 139.36 | 76.26 |
Working Capital | 9,964 | 10,488 | 871.85 | 242.32 | 150.69 |
Book Value Per Share | 70.67 | 72.94 | 10.57 | 5.79 | 7.74 |
Tangible Book Value | 11,133 | 11,455 | 1,436 | 764.24 | 542.87 |
Tangible Book Value Per Share | 70.46 | 72.73 | 10.30 | 5.48 | 7.12 |
Machinery | 289.92 | 284 | 270.28 | 34.39 | 28.33 |
Construction In Progress | - | 7.05 | 14.98 | 218.93 | 166.23 |
Leasehold Improvements | 44.73 | 34.64 | 20.09 | 9.71 | 9.71 |